Semaglutide (Glp-1 Receptor Agonist) Injectable Solution Suppliers & Bulk Manufacturers

Available Forms: Injectable solution (prefilled pen)

Available Strengths: 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL

Reference Brands: Ozempic(EU & US)

Category: Diabetes

Semaglutide (GLP-1 receptor agonist) Injectable solution is available in Injectable solution (prefilled pen) and strengths such as 0.25 mg/0.5 mL, 0.5 mg/0.5 mL, 1 mg/0.5 mL, 2 mg/0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Semaglutide (GLP-1 receptor agonist) Injectable solution is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Semaglutide (GLP-1 receptor agonist) Injectable solution can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Semaglutide, a GLP-1 receptor agonist available as an injectable solution (e.g., Ozempic, Wegovy), is FDA-approved in the USA for type 2 diabetes and chronic weight management in adults. It requires Boxed Warnings for potential thyroid C-cell tumors and must meet GMP, labeling, and post-marketing surveillance standards. In the EU, semaglutide is centrally approved by the EMA for the same indications, with stringent requirements for Risk Management Plans (RMPs) and pharmacovigilance reporting. Ongoing clinical safety and batch quality oversight are essential in both markets. Explore compliant supply options at Pharmatradz.com.